Results 301 to 310 of about 11,357,056 (401)

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg   +10 more
wiley   +1 more source

Thyroid Function and All-cause Mortality in the Context of Multimorbidity: Results From 2 Population-based Studies.

open access: yesJ Clin Endocrinol Metab
Xu Y   +6 more
europepmc   +1 more source

Two Pillars of My Path in Cytopathology: Mentorship From Training to Practice

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT Mentorship has been a cornerstone of my professional development in cytopathology, shaping both my diagnostic acumen and academic identity. Under the guidance of Dr. Claire Michael during residency and fellowship, I was introduced to a culture of intellectual rigor, systems thinking, and continuous improvement.
Hamza N. Gokozan
wiley   +1 more source

Preoperative Detection of Dual TERT Promoter Mutations in Thyroid Cancer: A Case Series

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT Telomerase reverse transcriptase promoter (TERTp) mutations are associated with aggressive thyroid cancer and are most frequently found in anaplastic and poorly differentiated thyroid cancer. Pre‐operative thyroid nodule molecular testing can detect TERTp, denoting a high risk of malignancy and possible aggressive clinical features such as ...
Amir Harari   +7 more
wiley   +1 more source

Association between thyroid function and metabolic associated fatty liver disease: a systemic review and meta-analysis. [PDF]

open access: yesFront Endocrinol (Lausanne)
Xiong W   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy